Tag: Centers for Medicare and Medicaid Services

New Sunshine Reporting FAQs Released by CMS

As announced last week, the Centers for Medicare & Medicaid Services (CMS) issued another round of FAQs related to the implementation of the Sunshine Act.  Below is a list of the 20 new CMS FAQs organized by category with a link to the answer from CMS for each.  Cooley’s CMS Sunshine FAQs trackers also have been […]

Physician Organizations Ask CMS to Exclude Reprints, Textbooks from Sunshine Reporting

Earlier this week, 74 medical associations and societies sent a letter to the Centers for Medicare & Medicaid Services (CMS) asking it to exclude journal reprints and textbooks from federal Sunshine reporting requirements.  The physician organizations argued that CMS’ requirement for industry to report these items as gifts or transfers of value to physicians is […]

A Few Good Nuggets Related to Sunshine at Industry Conference

Today at the Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (PCF), the audience heard from Anita Griner, Deputy Director at the Centers for Medicare & Medicaid Services (CMS) who has responsibility related to Open Payments.  In addition to providing an overview of Sunshine implementation, Ms. Griner provided a […]

CMS Issues Another Round of Sunshine Reporting FAQs

The Centers for Medicare & Medicaid Services (CMS) issued today another round of FAQs related to the implementation of the Sunshine Act.  Pharmaceutical, biotechnology and medical device manufacturers and group purchasing organizations (GPOs) started tracking data on August 1, 2013.  Below is a list of the new 25 CMS FAQs organized […]

CMS Call for Comments Re: Sunshine Act

The Centers for Medicare & Medicaid Services (CMS) recently issued a Federal Register notice requesting comments related to the Sunshine Act, section 6002 of the Affordable Care Act.  Specifically, CMS is requesting comments on the implementation of the registration process, attestation process, dispute and resolution processes, assumptions document, and data retention requirements […]

TIME IS UP! Sunshine Data Tracking Starts Today

The day long awaited by the health care industry has finally arrived.  Today is the day that pharmaceutical, biotechnology and medical device manufacturers and group purchasing organizations (GPOs) must begin tracking payments and other transfers of value provided to “covered recipients” in accordance with Section 6002 of the Affordable Care Act (commonly […]

CMS Releases New Information About State Medicaid Drug Utilization Review Practices

On July 30, 2013, the Centers for Medicare & Medicaid Services (“CMS”) posted state annual Medicaid DUR reports for fiscal year 2012.  States are required to complete annual Medicaid drug utilization review (“DUR”) surveys outlining prescribing habits, and describing cost savings generated from state Medicaid DUR programs and their Medicaid program’s […]